CarsonAllaria Wealth Management’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-150
Closed -$441 – 355
2024
Q3
$441 Hold
150
– – ﹤0.01% 380
2024
Q2
$522 Hold
150
– – ﹤0.01% 362
2024
Q1
$428 Hold
150
– – ﹤0.01% 381
2023
Q4
$530 Hold
150
– – ﹤0.01% 342
2023
Q3
$389 Hold
150
– – ﹤0.01% 352
2023
Q2
$591 Hold
150
– – ﹤0.01% 371
2023
Q1
$507 Hold
150
– – ﹤0.01% 356
2022
Q4
$1K Hold
150
– – ﹤0.01% 305
2022
Q3
$1K Hold
150
– – ﹤0.01% 304
2022
Q2
$1K Hold
150
– – ﹤0.01% 300
2022
Q1
$1K Buy
+150
New +$1.05K ﹤0.01% 312

Other funds holding SRTA

CarsonAllaria Wealth Management's SRTA Position: Q4 2024 in Review

CarsonAllaria Wealth Management sold out of Strata Critical Medical Inc (SRTA) in Q4 2024, closing a stake of 150 shares — an estimated $441 sold.

CarsonAllaria Wealth Management first reported a position in SRTA in Q1 2022 and held it in 11 quarters. The position peaked at $1K in Q4 2022. 122 funds tracked by Wall St. Rank hold SRTA as of Q4 2024.

  • CarsonAllaria Wealth Management reported no remaining Strata Critical Medical Inc position as of Q4 2024 after selling out during the quarter.
  • CarsonAllaria Wealth Management sold 150 Strata Critical Medical Inc shares in Q4 2024, an estimated $441.
  • CarsonAllaria Wealth Management first reported a position in Strata Critical Medical Inc in Q1 2022 and held it in 11 quarters.
  • CarsonAllaria Wealth Management's Strata Critical Medical Inc position peaked at $1K in Q4 2022.
  • 122 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q4 2024.

Based on CarsonAllaria Wealth Management's 13F filing for Q4 2024, filed 27 Jan 2025.